Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury

Study ID: NCT05951777
Start Date: 2024-04-16
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

51

Intervention / Treatment

Autologous HB-adMSCs

Normal Saline

Sponsor

Hope Biosciences LLC

Source: clinicaltrials.gov

Share:
Add to list

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Study ID: NCT06216301
Start Date: 2024-07-31
End Date: 2028-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

734

Intervention / Treatment

NovoTTF-200T

Pembrolizumab

Platinum based chemotherapy

Sponsor

NovoCure GmbH

Source: clinicaltrials.gov

Share:
Add to list

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Study ID: NCT04927416
Start Date: 2021-10-25
End Date: 2030-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

54

Intervention / Treatment

68-Gallium-DOTATATE-PET/CT

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

Two Versus One Week Breast Radiotherapy (RT)

Study ID: NCT06960707
Start Date: 2025-04-29
End Date: 2040-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

Radiation therapy - 1 week

Radiation therapy - 2 weeks

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction

Study ID: NCT06634030
Start Date: 2025-04-01
End Date: 2026-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

RhPDGF-BB

Saline

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Radiosurgery (SRS) Dose-Escalation Study for Brain Metastasis

Study ID: NCT02645487
Start Date: 2015-12-18
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

135

Intervention / Treatment

Stereotactic Radiosurgery

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Developing and Testing an Online Pathway From Screening to Treatment for Depression in Oncology: iPath*D (Aim 2)

Study ID: NCT05302375
Start Date: 2024-07-01
End Date: 2025-12-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

iPath*D

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

CAR-T Cell Therapy, Mosunetuzumab and Polatuzumab for Treatment of Refractory/Relapsed Aggressive Non-Hodgkin's Lymphoma (NHL).

Study ID: NCT05260957
Start Date: 2022-12-14
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

22

Intervention / Treatment

Mosunetuzumab

Polatuzumab

CAR-T Cell Therapy

Sponsor

Lazaros Lekakis

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Study ID: NCT06253871
Start Date: 2024-03-25
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase1

No. of Participants

243

Intervention / Treatment

IAM1363

Sponsor

Iambic Therapeutics, Inc

Source: clinicaltrials.gov

Share:
Add to list

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Study ID: NCT04322734
Start Date: 2023-12-13
End Date: 2028-12-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

Southwest Autism Research & Resource Center

Source: clinicaltrials.gov

Share:
Add to list